OPKO Health Announces Global License Agreement for the Discovery of Novel Antimicrobials
September 09, 2015 at 09:00 AM EDT
OPKO Health, Inc. (NYSE: OPK) today announced a global license agreement with The Scripps Research Institute (TSRI) for the development ...
